Cebula B - Search Results

1

The role of NF-κB and Smac/DIABLO proteins in the treatment response and survival of acute myeloid leukemia patients.

Pluta A, Robak T, Cebula B, Majchrzak A, Pluta P, Brzozowski K, Stępka K, Szmigielska-Kapłon A, Grzybowska-Izydorczyk O, Czemerska M, Smolewski P, Wierzbowska A. Pluta A, et al. Among authors: cebula b. Arch Med Sci. 2019 Nov 19;17(3):700-707. doi: 10.5114/aoms.2019.89918. eCollection 2021. Arch Med Sci. 2019. PMID: 34025840 Free PMC article.

2

Circulating endothelial cells in patients with acute myeloid leukemia.

Wierzbowska A, Robak T, Krawczyńska A, Wrzesień-Kuś A, Pluta A, Cebula B, Smolewski P. Wierzbowska A, et al. Among authors: cebula b. Eur J Haematol. 2005 Dec;75(6):492-7. doi: 10.1111/j.1600-0609.2005.00549.x. Eur J Haematol. 2005. PMID: 16313261

3

Rituximab plus cladribine with or without cyclophosphamide in patients with relapsed or refractory chronic lymphocytic leukemia.

Robak T, Smolewski P, Cebula B, Grzybowska-Izydorczyk O, Błoński JZ. Robak T, et al. Among authors: cebula b. Eur J Haematol. 2007 Aug;79(2):107-13. doi: 10.1111/j.1600-0609.2007.00889.x. Eur J Haematol. 2007. PMID: 17635235 Clinical Trial.

4

Kinetics and apoptotic profile of circulating endothelial cells as prognostic factors for induction treatment failure in newly diagnosed acute myeloid leukemia patients.

Wierzbowska A, Robak T, Krawczyńska A, Pluta A, Wrzesień-Kuś A, Cebula B, Robak E, Smolewski P. Wierzbowska A, et al. Among authors: cebula b. Ann Hematol. 2008 Feb;87(2):97-106. doi: 10.1007/s00277-007-0372-9. Epub 2007 Sep 11. Ann Hematol. 2008. PMID: 17849117

5

Rapamycin, the mTOR kinase inhibitor, sensitizes acute myeloid leukemia cells, HL-60 cells, to the cytotoxic effect of arabinozide cytarabine.

Janus A, Linke A, Cebula B, Robak T, Smolewski P. Janus A, et al. Among authors: cebula b. Anticancer Drugs. 2009 Sep;20(8):693-701. doi: 10.1097/CAD.0b013e32832e89b4. Anticancer Drugs. 2009. PMID: 19584709

6

Expression and prognostic significance of the inhibitor of apoptosis protein (IAP) family and its antagonists in chronic lymphocytic leukaemia.

Grzybowska-Izydorczyk O, Cebula B, Robak T, Smolewski P. Grzybowska-Izydorczyk O, et al. Among authors: cebula b. Eur J Cancer. 2010 Mar;46(4):800-10. doi: 10.1016/j.ejca.2009.11.023. Epub 2010 Jan 4. Eur J Cancer. 2010. PMID: 20045309

7

Proapoptotic activity of alemtuzumab alone and in combination with rituximab or purine nucleoside analogues in chronic lymphocytic leukemia cells.

Smolewski P, Szmigielska-Kaplon A, Cebula B, Jamroziak K, Rogalinska M, Kilianska Z, Robak T. Smolewski P, et al. Among authors: cebula b. Leuk Lymphoma. 2005 Jan;46(1):87-100. doi: 10.1080/13693780400007151. Leuk Lymphoma. 2005. PMID: 15621786

8

Rituximab combined with cladribine or with cladribine and cyclophosphamide in heavily pretreated patients with indolent lymphoproliferative disorders and mantle cell lymphoma.

Robak T, Smolewski P, Cebula B, Szmigielska-Kaplon A, Chojnowski K, Blonski JZ. Robak T, et al. Among authors: cebula b. Cancer. 2006 Oct 1;107(7):1542-50. doi: 10.1002/cncr.22196. Cancer. 2006. PMID: 16948126 Free article. Clinical Trial.

9

Cladribine combined with high doses of arabinoside cytosine, mitoxantrone, and G-CSF (CLAG-M) is a highly effective salvage regimen in patients with refractory and relapsed acute myeloid leukemia of the poor risk: a final report of the Polish Adult Leukemia Group.

Wierzbowska A, Robak T, Pluta A, Wawrzyniak E, Cebula B, Hołowiecki J, Kyrcz-Krzemień S, Grosicki S, Giebel S, Skotnicki AB, Piatkowska-Jakubas B, Kuliczkowski K, Kiełbiński M, Zawilska K, Kłoczko J, Wrzesień-Kuś A; Polish Adult Leukemia Group. Wierzbowska A, et al. Among authors: cebula b. Eur J Haematol. 2008 Feb;80(2):115-26. doi: 10.1111/j.1600-0609.2007.00988.x. Epub 2007 Dec 11. Eur J Haematol. 2008. PMID: 18076637

10

The effect of repeated exposures to low-dose UV radiation on the apoptosis of peripheral blood mononuclear cells.

Narbutt J, Cebula B, Lesiak A, Sysa-Jedrzejowska A, Norval M, Robak T, Smolewski P. Narbutt J, et al. Among authors: cebula b. Arch Dermatol. 2009 Feb;145(2):133-8. doi: 10.1001/archdermatol.2008.574. Arch Dermatol. 2009. PMID: 19221257 Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

26 results

Search Page